Lincoln Diagnostics LLC

Lincoln Diagnostics LLC was paid $24.29M by Medicaid between Jan 2018 and Dec 2024, across 320 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 23% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in New Jersey

Rank by total paid#16 of 122

Median peer was paid$1.29M

This provider vs. median19×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	7,021	$43K
2019	20,674	$165K
2020	61,791	$1.51M
2021	213,197	$5.98M
2022	304,182	$6.44M
2023	394,242	$4.85M
2024incomplete	386,585	$5.31M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	23%	85,820	70,907	$5.57M
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	19%	53,233	50,786	$4.74M
87631		7.4%	34,082	32,520	$1.81M
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	6.8%	82,383	69,747	$1.66M
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	3.3%	16,017	14,738	$812K
87486		2.7%	46,236	44,244	$647K
87581		2.4%	46,226	44,231	$576K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	2.3%	32,672	32,402	$571K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	2.1%	27,538	26,511	$511K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	1.5%	5,034	4,803	$371K
88305	Level IV - Surgical pathology, gross and microscopic examination	1.4%	7,885	7,714	$350K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	1.4%	9,990	9,653	$338K

308 more codes

86769		1.0%	6,660	$250K
80050	General health panel	<1%	15,769	$232K
82607		<1%	29,058	$213K
0202U	Oncology (prostate), multianalyte, gene expression profiling	<1%	1,097	$204K
83036	Hemoglobin; glycosylated (A1C)	<1%	36,953	$203K
80053	Comprehensive metabolic panel	<1%	30,533	$175K
86480		<1%	5,559	$172K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	12,106	$171K
84439		<1%	29,175	$153K
82746		<1%	21,088	$153K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	12,136	$153K
82728		<1%	17,895	$143K
87481		<1%	7,731	$137K
80061	Lipid panel	<1%	37,678	$135K
84481		<1%	23,258	$121K
84443	Thyroid stimulating hormone (TSH)	<1%	24,173	$119K
83970		<1%	4,956	$102K
83013		<1%	2,970	$92K
80074		<1%	3,902	$92K
86003		<1%	2,385	$78K
87653		<1%	6,768	$78K
87640		<1%	6,731	$78K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	7,621	$77K
87563		<1%	6,368	$75K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	7,045	$75K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	13,108	$74K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	11,920	$73K
84153		<1%	6,614	$69K
87536		<1%	1,205	$68K
88120		<1%	748	$68K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	36,489	$67K
88312		<1%	4,196	$62K
82670		<1%	3,937	$59K
86706		<1%	11,200	$59K
84466		<1%	8,558	$57K
88342		<1%	2,222	$57K
83880		<1%	2,965	$55K
86708		<1%	8,288	$52K
86696		<1%	5,347	$52K
81001		<1%	27,736	$51K
83540		<1%	16,989	$49K
86704		<1%	7,719	$46K
84403		<1%	3,118	$46K
87340		<1%	10,920	$46K
87086	Culture, bacterial; quantitative colony count, urine	<1%	9,628	$46K
84154		<1%	4,383	$46K
86803		<1%	10,688	$43K
86762		<1%	4,629	$41K
84550		<1%	15,400	$39K
83090		<1%	3,789	$38K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	<1%	2,084	$38K
86765		<1%	4,640	$37K
83735		<1%	11,701	$35K
86141		<1%	6,406	$34K
87150		<1%	625	$33K
88313		<1%	2,336	$32K
81514		<1%	1,050	$31K
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	<1%	1,017	$30K
82378		<1%	2,547	$29K
88304		<1%	1,060	$28K
86235		<1%	2,326	$27K
84144		<1%	2,387	$27K
86709		<1%	7,904	$25K
83001		<1%	2,517	$25K
83002		<1%	2,473	$25K
87070		<1%	5,356	$24K
83550		<1%	8,776	$22K
86735		<1%	4,479	$22K
83655		<1%	2,955	$22K
84146		<1%	2,035	$21K
83525		<1%	3,229	$21K
86695		<1%	4,884	$21K
82652		<1%	2,924	$20K
84402		<1%	1,562	$20K
82533		<1%	2,318	$19K
88112		<1%	1,198	$19K
86376		<1%	2,261	$18K
82627		<1%	1,618	$18K
82043		<1%	6,048	$18K
86592		<1%	7,838	$17K
86780		<1%	2,198	$17K
86787		<1%	3,543	$17K
84270		<1%	3,738	$17K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	1,179	$17K
85651		<1%	13,945	$17K
85730		<1%	4,754	$16K
88311		<1%	2,334	$16K
87512		<1%	927	$14K
82785		<1%	2,015	$14K
80048	Basic metabolic panel (calcium, ionized)	<1%	3,289	$13K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	727	$13K
83690		<1%	4,235	$13K
86038		<1%	4,468	$13K
82248		<1%	4,058	$12K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	987	$12K
83992		<1%	2,685	$12K
82150		<1%	4,915	$12K
85610		<1%	5,111	$12K
84207		<1%	729	$11K
86800		<1%	1,467	$11K
86705		<1%	4,809	$11K
80076		<1%	2,581	$10K
86618		<1%	1,040	$10K
87799		<1%	790	$9K
82784		<1%	1,650	$9K
87634		<1%	2,326	$9K
81000		<1%	3,702	$9K
84436		<1%	12,828	$8K
84305		<1%	758	$8K
86225		<1%	2,874	$8K
83516		<1%	1,581	$8K
82172		<1%	663	$7K
86431		<1%	2,360	$7K
86140		<1%	3,044	$7K
84702		<1%	866	$7K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	179	$7K
80345		<1%	3,210	$7K
87109		<1%	945	$6K
86258		<1%	1,132	$6K
88142		<1%	377	$6K
86665		<1%	314	$6K
84425		<1%	769	$6K
80349		<1%	3,480	$6K
86255		<1%	1,902	$6K
84446		<1%	877	$6K
82570		<1%	3,926	$6K
86901		<1%	3,265	$6K
88174		<1%	367	$6K
82180		<1%	987	$5K
84432		<1%	1,127	$5K
86301		<1%	466	$5K
86200		<1%	1,499	$5K
84630		<1%	1,125	$5K
84140		<1%	473	$5K
82977		<1%	1,882	$5K
80324		<1%	2,744	$5K
84590		<1%	834	$5K
86900		<1%	2,718	$5K
80323		<1%	2,058	$4K
80336		<1%	2,670	$4K
87522	Neg quan hep c or qual rna	<1%	182	$4K
87500		<1%	294	$4K
82550		<1%	1,449	$4K
80320		<1%	1,651	$4K
87186		<1%	1,083	$4K
84479		<1%	10,506	$4K
80346		<1%	2,747	$4K
80354		<1%	1,794	$4K
83921		<1%	354	$3K
84100		<1%	1,392	$3K
86364		<1%	961	$3K
82525		<1%	500	$3K
80338		<1%	637	$3K
88360		<1%	220	$3K
82105		<1%	1,036	$3K
86304		<1%	311	$3K
84482		<1%	983	$3K
84252		<1%	1,062	$3K
82465		<1%	2,456	$3K
86664		<1%	309	$3K
83520		<1%	997	$3K
84255		<1%	913	$3K
80365		<1%	2,745	$3K
83695		<1%	1,026	$3K
85045		<1%	1,490	$3K
86663		<1%	307	$3K
80359		<1%	2,615	$3K
87517		<1%	445	$3K
87912		<1%	74	$3K
80361		<1%	1,021	$2K
80358		<1%	2,326	$2K
83615		<1%	995	$2K
80353		<1%	2,428	$2K
80360		<1%	1,866	$2K
84156		<1%	1,166	$2K
82108		<1%	164	$2K
87350		<1%	296	$2K
80348		<1%	1,947	$2K
80373		<1%	2,022	$2K
86060		<1%	762	$2K
86008		<1%	274	$2K
86774		<1%	528	$2K
86037		<1%	309	$2K
80370		<1%	1,600	$2K
80368		<1%	1,605	$2K
80371		<1%	1,599	$2K
80372		<1%	1,599	$2K
84681		<1%	173	$2K
80171		<1%	254	$2K
84478		<1%	1,615	$2K
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	<1%	322	$2K
80356		<1%	1,942	$2K
85660		<1%	971	$2K
86360		<1%	47	$2K
83825		<1%	170	$2K
87511		<1%	527	$1K
86039		<1%	556	$1K
83721		<1%	1,230	$1K
86677		<1%	260	$1K
86317		<1%	584	$1K
82553		<1%	360	$1K
P9604	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge	<1%	616	$1K
82040		<1%	496	$1K
86671		<1%	173	$1K
80351		<1%	1,748	$1K
86648		<1%	497	$1K
80299		<1%	202	$1K
82495		<1%	159	$1K
87507		<1%	12	$1K
81256		<1%	137	$1K
82103		<1%	194	$995.27
86617		<1%	62	$974.70
85384		<1%	265	$925.07
G0482	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed	<1%	189	$914.12
85379		<1%	162	$891.23
85027		<1%	490	$878.50
82390		<1%	250	$877.69
82985		<1%	169	$851.30
82530		<1%	101	$799.76
87324		<1%	150	$797.73
86707		<1%	112	$784.76
87177		<1%	176	$769.94
84484		<1%	186	$758.99
80363		<1%	1,417	$754.57
84480		<1%	2,750	$746.09
86256		<1%	87	$548.46
83718		<1%	1,296	$546.14
84378		<1%	91	$543.20
82672		<1%	53	$536.03
87101		<1%	128	$502.32
87081		<1%	153	$483.44
83874		<1%	118	$475.70
83003		<1%	50	$445.68
86300		<1%	36	$439.16
87209		<1%	146	$435.08
87045		<1%	73	$426.74
87641		<1%	52	$419.68
80352		<1%	126	$417.85
85032		<1%	412	$405.65
82232		<1%	64	$401.36
86381		<1%	58	$390.84
83010		<1%	81	$385.64
88141		<1%	68	$344.66
82677		<1%	35	$317.99
85014		<1%	414	$315.05
87338		<1%	82	$313.39
86160		<1%	28	$272.14
84460		<1%	251	$263.65
82247		<1%	290	$245.74
83698		<1%	69	$239.76
82552		<1%	46	$214.61
85048		<1%	220	$210.80
83631		<1%	37	$200.73
86021		<1%	55	$198.78
83993		<1%	32	$198.39
82175		<1%	25	$192.63
86036		<1%	59	$183.70
86015		<1%	61	$183.66
87510		<1%	20	$181.79
87660		<1%	19	$167.70
84311		<1%	100	$158.11
82542		<1%	164	$154.71
87480		<1%	20	$153.61
86316		<1%	16	$152.02
84134		<1%	55	$151.40
80362		<1%	260	$147.26
80367		<1%	188	$142.25
87102		<1%	28	$139.25
81025		<1%	131	$137.45
84075		<1%	119	$125.90
82310		<1%	122	$125.88
87449		<1%	64	$124.47
82947		<1%	204	$120.46
82656		<1%	40	$112.20
84450		<1%	118	$110.60
84597		<1%	16	$105.49
82747		<1%	24	$104.90
80069		<1%	28	$104.56
84520		<1%	128	$104.28
84155		<1%	174	$93.80
83020		<1%	12	$93.34
83883		<1%	38	$90.33
80355		<1%	67	$85.00
82565		<1%	122	$80.36
80366		<1%	70	$80.00
86341		<1%	13	$73.69
85004		<1%	319	$70.10
83789		<1%	40	$63.62
84132		<1%	135	$63.37
87341		<1%	12	$62.00
82374		<1%	172	$56.78
87088		<1%	14	$53.86
84591		<1%	26	$50.37
87046		<1%	19	$48.44
84295		<1%	168	$41.10
36415	Collection of venous blood by venipuncture	<1%	194	$35.40
82270		<1%	23	$28.76
82435		<1%	115	$27.60
80347		<1%	175	$16.00
85049		<1%	81	$15.27
83630		<1%	37	$10.46
85018		<1%	81	$8.40
81003		<1%	60	$1.62
81002		0%	239	$0.00
99080		0%	147	$0.00
82671		0%	14	$0.00
83986		0%	60	$0.00
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	0%	52	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialLEONARDO, ANDALIS (CEO)